Molecular basis of muscle hypertrophy and atrophy: Potential therapy for muscular dystrophy
Skeletal muscle mass is regulated by a balance of protein synthesis and degradation. The regulation of this protein synthesis/degradation system is linked with muscle activity, and leads to muscle hypertrophy/atrophy. However, recent studies suggested that this system is also linked to the mechanism...
Saved in:
Main Authors: | Naoki Ito (Author), Yuko Miyagoe-Suzuki (Author), Shin'ichi Takeda (Author) |
---|---|
Format: | Book |
Published: |
Japanese Society of Physical Fitness and Sports Medicine,
2013-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Ca2+ signaling in skeletal muscle hypertrophy and atrophy
by: Naoki Ito, et al.
Published: (2015) -
Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status
by: Yuko Miyagoe-Suzuki, et al.
Published: (2017) -
Changes in cytosolic Ca2+ dynamics in the sarcoplasmic reticulum associated with the pathology of Duchenne muscular dystrophy
by: Jun Tanihata, et al.
Published: (2016) -
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
by: Pradeep Harish, et al.
Published: (2019) -
NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy
by: Naoki Watanabe, et al.
Published: (2018)